Alpine Global Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$43.82 - $85.37 $435,570 - $848,577	-9,940 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $330,107 - $509,623	9,940 New	9,940 $428,000
Q2 2018 Aug 15, 2018	SELL	$6.37 - $14.02 $185,239 - $407,701	-29,080 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$3.72 - $7.64 $69,203 - $142,126	-18,603 Reduced 39.01%	29,080 $210,000
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $149,724 - $214,573	47,683	47,683 $175,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.